Bioavailability and bioequivalence (BA/BE) studies in the Asia-Pacific region are gaining significant momentum. The rising cost of medicines worldwide is driving a strong demand for more affordable healthcare options. In this context, the generic drug market is emerging as a promising alternative, offering consumers access to medications at more reasonable prices. To bring generic drugs […]

Read More →

Thailand is rapidly emerging as a key player in the global clinical trial landscape, with the market expected to reach USD 3.5 billion by 2027. The country’s strategic location in Southeast Asia provides access to a diverse patient population, essential for robust clinical research. Moreover, Thailand’s healthcare system is well-equipped with state-of-the-art facilities and skilled […]

Read More →

Clinical trial site identification and feasibility are critical components of the clinical trial process. Selecting the right sites and ensuring they are feasible for conducting trials can greatly impact the success and efficiency of clinical trials. The process begins with identifying potential sites that have the appropriate infrastructure, patient population, and experience. The right site […]

Read More →

Clinical trial monitoring is a critical process that ensures the integrity, safety, and compliance of clinical research. Key strategies in clinical trial monitoring thus include rigorous planning, execution, and oversight to maintain data quality and patient safety. Effective monitoring begins with understanding the trial protocol, regulatory requirements, and ethical guidelines. Monitoring involves several activities, including […]

Read More →

Clinical trials are the cornerstone of medical advancements, providing essential data to determine the safety and efficacy of new treatments. The global clinical trials market is expected to reach USD 83.5 billion by 2028, highlighting the growing significance of well-planned trials. But, 86% of clinical trials experience delays, often due to poor planning. By implementing […]

Read More →

Bioavailability (BA) and bioequivalence (BE) studies in India are crucial in drug development and regulatory approval processes. These studies ensure that generic drugs are therapeutically equivalent to their branded counterparts and that new formulations perform adequately. The importance of BA/BE studies has grown significantly in India, driven by the burgeoning pharmaceutical industry and stringent regulatory […]

Read More →

Electronic data capture (EDC) has revolutionized the management of clinical trials, offering significant impacts and advantages over traditional paper-based methods. In clinical trials, precise and efficient data collection is crucial for ensuring the integrity and accuracy of research findings. EDC systems streamline this process by allowing researchers to enter data directly into digital platforms. The […]

Read More →

Pharmaceutical research and development in the Asia-Pacific (APAC) region now heavily relies on clinical trial sourcing. Collaborating with research institutions and healthcare organizations fosters international research partnerships and facilitates knowledge exchange. Most countries in the Asia-Pacific region tend to seek this help because it brings several benefits. The success of clinical trials depends on the […]

Read More →

Choosing Australia for nutraceutical trials offers several advantages. The country’s high-quality research infrastructure, skilled workforce, and efficient regulatory environment ensure reliable results and faster approvals. As of now, there are numerous clinical trials ongoing and completed in Australia focusing on nutraceuticals and complementary medicines. The NICM Health Research Institute at Western Sydney University is a […]

Read More →

India is becoming a popular choice for clinical trials due to several key advantages and benefits. The country offers a promising environment with a diverse patient population, making it ideal for gathering comprehensive data. With a population exceeding 1.3 billion, including a substantial patient pool across various demographics and medical conditions, India offers a vast […]

Read More →